Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation

Hongxu Xian; Yuan Liu; A. Nilsson; Raphaella Gatchalian; Timothy R. Crother; Warren G. Tourtellotte; Yi Zhang; Germán Rodrigo Alemán-Muench; Gavin Lewis; Weixuan Chen; Sarah Kang; Melissa Luevanos; Dorit Trudler; Stuart A. Lipton; Pejman Soroosh; John R. Teijaro; Juan Carlos de la Torre; Moshe Arditi; Michael Karin; Elsa Sánchez‐López

doi:10.1016/j.immuni.2021.05.004

Related publications

Article2018

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

Zhenyu Zhong, Shuang Liang, Elsa Sánchez‐López, Feng He, Shabnam Shalapour, Xue-Jia Lin, Jerry Wong, Siyuan Ding, Ekihiro Seki, Bernd Schnabl, Andrea L. Hevener, Harry B. Greenberg, Tatiana Kisseleva, Michael Karin

Letter2011

Mitochondrial control of the NLRP3 inflammasome

Oliver Kepp, Lorenzo Galluzzi, Guido Guido Kroemer

Article2016

NF-κB restricts NLRP3 inflammasome activation via p62-dependent mitophagy which eliminates mitochondrial signals

Zhenyu Zhong, Atsushi Umemura, Elsa Sánchez‐López, Shuang Liang, Shabnam Shalapour, Jerry Wong, Feng He, Daniela Boassa, Guy Perkins, Syed R. Ali, Matthew G McGeough, Mark H. Ellisman, Ekihiro Seki, Åsa B. Gustafsson, Hal M. Hoffman, María T. Díaz‐Meco, Jorge Moscat, Michael Karin

Dataset

Faculty Opinions recommendation of NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.

Ralf Weiskirchen

Article2020

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation

Alexander Hooftman, Stefano Angiari, Svenja Hester, Sarah E. Corcoran, Marah C. Runtsch, Chris Ling, Melanie C. Ruzek, Peter F. Slivka, Anne F. McGettrick, Kathy Banahan, Mark Hughes, Alan D. Irvine, Román Fischer, Luke O'neill

Cell Metabolism